Early buyers will receive 10% customization on this report.
This report studies the global healthcare cloud computing market for the forecast period of 2015 to 2020. This market is expected to reach $9.48 Billion by 2020 from $3.73 Billion in 2015 at a CAGR of 20.5% during the forecast period.
Industry Dynamics:
Over the years, the adoption of cloud computing in healthcare is likely to increase owing to the rising need to curtail healthcare costs and enhance the quality of healthcare, reforms benefiting healthcare IT, proliferation of new payment models and cost-efficiency of cloud technology, and the implementation of the Patient Protection and Affordable Care Act (PPACA).
Moreover, teleCloud and the formation of accountable care organizations (ACOs) are creating growth opportunities for the healthcare cloud computing market. However, the security of patient data on cloud is a crucial issue that is likely to restrain the growth of this market.
Geographical Analysis:
On the basis of regions, the market is divided into North America, Europe, Asia, and the Rest of the World (RoW). In 2015, North America is estimated to account for the largest share of the healthcare cloud computing market, followed by Europe and Asia. North America is expected to continue to grow at the highest CAGR during the forecast period.
Some major players in the global healthcare cloud computing market include athenahealth, Inc. (U.S.), CareCloud Corporation (U.S.), ClearData Networks, Inc. (U.S.), Carestream Health (U.S.), Dell Inc. (U.S.), GNAX Health (U.S.), IBM Corporation (U.S.), Iron Mountain, Inc. (U.S.), Merge Healthcare, Inc. (U.S.) and VMware, Inc. (U.S.).
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
